EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Leveraging Microphysiological Systems to Facilitate Neutrophil‐Based Cancer Immunotherapy

Shuai Shao iD, Markus Isfeld Diehl iD, Caroline N Jones iD

Advanced Science · 2026

DOI: 10.1002/advs.77572 ↗

At a glance

Übersichtsarbeit in Advanced Science, 2026. Written by Shuai Shao and 2 co-authors. Institution: Department of Bioengineering, The University of Texas at Dallas, Richardson, Texas, USA. Major MEDLINE topics: Neutrophils, Immunotherapy, Neoplasms. 316 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Science Foundation (NSF) CBET CAREER, Jonsson School Research Initiative (JSRI) at the University of Texas at Dallas, 2025 Bioengineering Convergent Grant at the University of Texas at Dallas.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Neutrophils are the most abundant immune cells in human blood and serve as the first line of defense against infection. However, the role of neutrophils in cancer progression is complex and context‐dependent, and they are underexplored as therapeutic targets for cancer compared with other immune cell types. Microphysiological systems, also known as complex in vitro models, have emerged as powerful tools for deciphering immune cell‐cancer interactions and preclinical drug testing due to the advantages of real‐time visualization of cell behaviors, precise control of microenvironments, and incorporation of human cells over in vivo animal models. This review first summarizes the multifaceted roles of neutrophils in cancer as defined by in vivo animal models and highlights recently developed strategies to mobilize neutrophils for cancer treatment. Next, current applications of different types of microphysiological systems, including 3D spheroids, organoids, and microfluidic organ‐on‐a‐chip platforms, for investigating the role of human neutrophils in cancer and evaluating neutrophil‐based cancer immunotherapies are surveyed. Lastly, future opportunities for microphysiological systems to address key challenges in the clinical translation of neutrophil‐based cancer immunotherapy are discussed.

Subjects

MeSH terms (MEDLINE)

NeutrophilsImmunotherapyNeoplasmsHumansMicrophysiological SystemsAnimalsTumor Microenvironment

Author keywords

cancerimmunotherapymicrophysiological systemneutrophilorgan‐on‐a‐chip

Authors and institutions

  • Department of Bioengineering, The University of Texas at Dallas, Richardson, Texas, USA.
  • Department of Biomedical Engineering, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Program in Immunology, Stanford University, Stanford, California, USA.
  • Department of Otolaryngology-Head and Neck Surgery (OHNS), Stanford University, Stanford, California, USA.

ORCID profiles: Shuai Shao, Markus Isfeld Diehl, Caroline N Jones

Funding

  • National Science Foundation (NSF) CBET CAREER
  • Jonsson School Research Initiative (JSRI) at the University of Texas at Dallas
  • 2025 Bioengineering Convergent Grant at the University of Texas at Dallas
  • Eugene McDermott Distinguished Professorship

Cite

APA

Shao, S., Diehl, M. I., & Jones, C. N. (2026). Leveraging Microphysiological Systems to Facilitate Neutrophil‐Based Cancer Immunotherapy. Advanced Science. https://doi.org/10.1002/advs.77572

Vancouver

Shao S, Diehl MI, Jones CN. Leveraging Microphysiological Systems to Facilitate Neutrophil‐Based Cancer Immunotherapy. Advanced Science. 2026. doi:10.1002/advs.77572

BibTeX
@article{Shao2026,
  author = {Shao, Shuai and Diehl, Markus Isfeld and Jones, Caroline N},
  title = {Leveraging Microphysiological Systems to Facilitate Neutrophil‐Based Cancer Immunotherapy},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.77572}
}
Start for free →